
    
      This is a randomized, double-blind, multiple ascending dose, placebo- and
      Hydrochlorothiazide-controlled study to evaluate the safety and tolerability,
      Pharmacokinetics and Pharmacodynamics and effect on blood pressure of SHR0532 tablets in
      patients with mild hypertension.
    
  